N,N'-Diacetyl-L-cystine

CAS No. 5545-17-5

N,N'-Diacetyl-L-cystine( DiNAC )

Catalog No. M26768 CAS No. 5545-17-5

N,N'-Diacetyl-L-cystine is the disulphide dimer of N-acetylcysteine with immunomodulating properties.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG Get Quote In Stock
200MG 31 In Stock
500MG 51 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    N,N'-Diacetyl-L-cystine
  • Note
    Research use only, not for human use.
  • Brief Description
    N,N'-Diacetyl-L-cystine is the disulphide dimer of N-acetylcysteine with immunomodulating properties.
  • Description
    N,N'-Diacetyl-L-cystine is the disulphide dimer of N-acetylcysteine with immunomodulating properties. N,N'-diacetyl-L-cystine also has antiatherosclerotic effects in Watanabe-heritable hyperlipidemic rabbit (WHHL) rabbits. N,N'-diacetyl-L-cystine is also an effective and orally active modulator of contact sensitivity/delayed-type hypersensitivity reactions in rodents.(In Vivo):N,N'-Diacetyl-L-cystine (DiNAC; 0-973.11 μg/kg; p.o.; daily; for 12 weeks; WHHL rabbits) treatment decreases by 50% thoracic aorta atherosclerosis. However, it has no affecting plasma lipid levels.
  • In Vitro
    ——
  • In Vivo
    N,N'-Diacetyl-L-cystine (DiNAC; 0-973.11 μg/kg; oral administration; daily; for 12 weeks; WHHL rabbits) treatment reduces by 50% thoracic aorta atherosclerosis, without affecting plasma lipid levels. Animal Model:Male heritable hyperlipidemic rabbit (WHHL) rabbits (10-22 weeks) Dosage:0 μg/kg, 9.73 μg/kg, or 973.11 μg/kg Administration:Oral administration; daily; for 12 weeks Result:Reduced by 50% thoracic aorta atherosclerosis, without affecting plasma lipid levels.
  • Synonyms
    DiNAC
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    CDK4/CyclinD1| CDK6/CyclinD3
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    5545-17-5
  • Formula Weight
    324.37
  • Molecular Formula
    C10H16N2O6S2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (385.36 mM)
  • SMILES
    O=C(O)[C@H](CSSC[C@@H](C(O)=O)NC(C)=O)NC(C)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.1. Ping Chen, et al. 2-amino-pyridine or 2-amino-pyrimidine derivatives as cyclin dependent kinase inhibitors. WO2019207463A1.
molnova catalog
related products
  • Neurotensin

    Neurotensin is a 13 amino acid neuropeptide that is implicated in the regulation of luteinizing hormone and prolactin release and has significant interaction with the dopaminergic system.

  • Nardosinone

    Nardosinone has inhibitory effect on Ang II-induced hypertrophy in H9c2 cells, might be mediated by targeting PI3K/Akt and MEK/ERK signaling pathways.

  • PKC ζ pseudosubstrat...

    Inhibitor of protein kinase C (PKC) ζ; attached to cell permeabilisation Antennapedia domain vector peptide. Consists of amino acids 113 - 129 of PKC ζ pseudosubstrate domain linked by a disulphide bridge to the Antennapedia domain vector peptide. The Antennapedia peptide is actively taken up by intact cells, at 4 or 37°C, ensuring rapid and effective uptake of the inhibitor peptide. Once inside the cell, the disulphide bonds are subjected to reduction in the cytoplasm leading to release of the inhibitor peptide. Induces mast cell degranulation by a PKC ζ-independent pathway.